| GTO ID | GTD0336 |
| Accession | E-MTAB-11315 |
| Gene therapy-related clinical trial | GTC2404 |
| Altered gene | S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment | ARCT-021(ARCT COVID-19 vaccine) |
| Control | Click to openARCT.101.1102.Day8_08;ARCT.101.1107.Day8_12;ARCT.101.2103.Day8_12;ARCT.101.2106.Day8_03;ARCT.101.2108.Day8_04;ARCT.101.2111.Day8_04;ARCT.101.3101.Day8_05;ARCT.101.3104.Day8_08;ARCT.101.4103.Day8_12;ARCT.101.4107.Day8_04;ARCT.101.4117.Day8_08;ARCT.101.4119.Day8_10;ARCT.101.5104.Day8_12;ARCT.101.5108.Day8_04;ARCT.101.5109.Day8_05;ARCT.101.5116.Day8_12;ARCT.101.6103.Day8_12;ARCT.101.6108.Day8_08;ARCT.101.6110.Day8_04;ARCT.101.6111.Day8_08;ARCT.101.7103.Day8_03;ARCT.101.7105.Day8_05;ARCT.101.7108.Day8_04;ARCT.101.7115.Day8_08;ARCT.101.8105.Day8_06;ARCT.101.8106.Day8_10;ARCT.101.8109.Day8_10;ARCT.101.8112.Day8_10 |
| Case | Click to openARCT.101.6101.Day8_04;ARCT.101.6102.Day8_08;ARCT.101.6104.Day8_04;ARCT.101.6105.Day8_08;ARCT.101.6106.Day8_12;ARCT.101.6107.Day8_04;ARCT.101.6109.Day8_12;ARCT.101.6112.Day8_12;ARCT.101.6113.Day8_04;ARCT.101.6114.Day8_08;ARCT.101.6115.Day8_12;ARCT.101.6116.Day8_04;ARCT.101.8101.Day8_02;ARCT.101.8102.Day8_06;ARCT.101.8103.Day8_10;ARCT.101.8104.Day8_02;ARCT.101.8107.Day8_02;ARCT.101.8108.Day8_06;ARCT.101.8110.Day8_02;ARCT.101.8111.Day8_06;ARCT.101.8113.Day8_02;ARCT.101.8114.Day8_06;ARCT.101.8115.Day8_10;ARCT.101.8116.Day8_02 |
| Disease | COVID-19 |
| Disease information |
Disease group: Infection Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2. Xref: DO:0080600 |
| Organism | Homo sapiens |
| Tissue/Cell type | blood |
| Characteristics | Day8;3 microgram |
| Strategy | Microarray |
| Platform | A-MTAB-668 |
| Gene Name | AveExpr Control | AveExpr Case | Log2FC | P-value | Adjusted P-value | Regulation | Boxplot |
|---|
| ID | Terms | Size | ES | NES | P-value | Adjusted P-value | Plot |
|---|